ID26420A - Indolinon-indolinon tersubstitusi baru, pembuatannya dan penggunaannya sebagai komposisi-komposisi farmasi - Google Patents

Indolinon-indolinon tersubstitusi baru, pembuatannya dan penggunaannya sebagai komposisi-komposisi farmasi

Info

Publication number: ID26420A
Authority: ID; Indonesia
Prior art keywords: indolinons; production; pharmaceutical compositions; new substituted; substituted
Prior art date: 1998-04-15

Application number

IDW20002062A

Other languages

English (en)

Inventor

Heckel Armin

Walter Rainer

Grell Wolfgang

Meel Jacobus Constant Antonius

Redemann Norbert

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-15

Filing date

1999-04-10

Publication date

2000-12-21

1999-04-10 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2000-12-21 Publication of ID26420A publication Critical patent/ID26420A/id

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Neurology (AREA)
Virology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Hospice & Palliative Care (AREA)
AIDS & HIV (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)

IDW20002062A 1998-04-15 1999-04-10 Indolinon-indolinon tersubstitusi baru, pembuatannya dan penggunaannya sebagai komposisi-komposisi farmasi ID26420A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19816624A DE19816624A1 (de)	1998-04-15	1998-04-15	Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number	Publication Date
ID26420A true ID26420A (id)	2000-12-21

Family

ID=7864562

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW20002062A ID26420A (id)	1998-04-15	1999-04-10	Indolinon-indolinon tersubstitusi baru, pembuatannya dan penggunaannya sebagai komposisi-komposisi farmasi

Country Status (31)

Country	Link
EP (1)	EP1071665B1 (id)
JP (1)	JP4015365B2 (id)
KR (1)	KR100588250B1 (id)
CN (1)	CN100338036C (id)
AR (1)	AR015763A1 (id)
AT (1)	ATE251138T1 (id)
AU (1)	AU749829B2 (id)
BG (1)	BG64443B1 (id)
BR (1)	BR9909688A (id)
CA (1)	CA2323111C (id)
CO (1)	CO5011040A1 (id)
DE (2)	DE19816624A1 (id)
DK (1)	DK1071665T3 (id)
EA (1)	EA003532B1 (id)
EE (1)	EE04432B1 (id)
ES (1)	ES2207209T3 (id)
HU (1)	HUP0101568A3 (id)
ID (1)	ID26420A (id)
IL (1)	IL138036A0 (id)
MY (1)	MY122357A (id)
NO (1)	NO317298B1 (id)
NZ (1)	NZ507967A (id)
PL (1)	PL343314A1 (id)
PT (1)	PT1071665E (id)
SK (1)	SK283824B6 (id)
TR (1)	TR200002980T2 (id)
TW (1)	TW510897B (id)
UA (1)	UA63009C2 (id)
WO (1)	WO1999052869A1 (id)
YU (1)	YU59800A (id)
ZA (1)	ZA200004623B (id)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6569868B2 (en)	1998-04-16	2003-05-27	Sugen, Inc.	2-indolinone derivatives as modulators of protein kinase activity
GB9904932D0 (en) *	1999-03-04	1999-04-28	Glaxo Group Ltd	Composition and method for preventing/reducing the severity of side effects of chemotherapy and/or radiation therapy
GB9904933D0 (en) *	1999-03-04	1999-04-28	Glaxo Group Ltd	Compounds
GB9904995D0 (en) *	1999-03-04	1999-04-28	Glaxo Group Ltd	Substituted aza-oxindole derivatives
US6624171B1 (en)	1999-03-04	2003-09-23	Smithkline Beecham Corporation	Substituted aza-oxindole derivatives
DE19924401A1 (de) *	1999-05-27	2000-11-30	Boehringer Ingelheim Pharma	Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
EP1212318B1 (de) *	1999-08-27	2006-01-25	Boehringer Ingelheim Pharma GmbH & Co.KG	Substituierte indolinone als tyrosinkinase inhibitoren
US6762180B1 (en)	1999-10-13	2004-07-13	Boehringer Ingelheim Pharma Kg	Substituted indolines which inhibit receptor tyrosine kinases
UA75054C2 (uk) *	1999-10-13	2006-03-15	Бьорінгер Інгельхайм Фарма Гмбх & Ко. Кг	Заміщені в положенні 6 індолінони, їх одержання та їх застосування як лікарського засобу
US6620818B1 (en)	2000-03-01	2003-09-16	Smithkline Beecham Corporation	Method for reducing the severity of side effects of chemotherapy and/or radiation therapy
TWI270545B (en)	2000-05-24	2007-01-11	Sugen Inc	Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
JP2003535847A (ja)	2000-06-02	2003-12-02	スージェン・インコーポレーテッド	蛋白質キナーゼ／ホスファターゼ阻害剤としてのインドリノン誘導体
CA2430151A1 (en) *	2000-11-27	2002-06-20	Pharmacia Italia S.P.A.	Phenylacetamido- pyrazole derivatives and their use as antitumor agents
DE10117204A1 (de)	2001-04-06	2002-10-10	Boehringer Ingelheim Pharma	In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
PE20030062A1 (es)	2001-05-30	2003-02-08	Sugen Inc	Derivados aralquilsulfonil-3-(pirrol-2-ilmetiliden)-2-indolinona como inhibidores de quinasas
DE60318188T2 (de)	2002-03-26	2008-12-11	Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield	Glucocorticoid-mimetika, deren herstellung, pharmazeutische zusammensetzungen und verwendung
US7169936B2 (en)	2002-07-23	2007-01-30	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments
DE10233500A1 (de) *	2002-07-24	2004-02-19	Boehringer Ingelheim Pharma Gmbh & Co. Kg	3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylen]-6-methoxycarbonyl-2-indolinon-Monoethansulfonat und dessen Verwendung als Arzneimittel
DE10237423A1 (de)	2002-08-16	2004-02-19	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verwendung von LCK-Inhibitoren für die Behandlung von immunologischen Erkrankungen
JP4879492B2 (ja) *	2002-11-27	2012-02-22	アラーガン、インコーポレイテッド	疾患の治療のためのキナーゼ阻害剤
US20050043233A1 (en)	2003-04-29	2005-02-24	Boehringer Ingelheim International Gmbh	Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
UY28526A1 (es)	2003-09-24	2005-04-29	Boehringer Ingelheim Pharma	Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
CA2541059C (en)	2003-10-03	2013-09-17	Boehringer Ingelheim Pharmaceuticals, Inc.	Fluorescent probes for use in protein kinase inhibitor binding assay
DE102004012070A1 (de) *	2004-03-12	2005-09-29	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue cycloalkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel
US7795272B2 (en)	2004-03-13	2010-09-14	Boehringer Ingelheim Pharmaceutical, Inc.	Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
PE20060777A1 (es)	2004-12-24	2006-10-06	Boehringer Ingelheim Int	Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
PE20060776A1 (es)	2004-12-27	2006-09-26	Boehringer Ingelheim Pharma	Mimeticos de glucocorticoides, metodos para prepararlos y composiciones farmaceuticas
US7781475B2 (en)	2005-06-10	2010-08-24	Merck Patent Gmbh	Oxindoles as kinase inhibitors
WO2007057399A2 (en) *	2005-11-15	2007-05-24	Boehringer Ingelheim International Gmbh	Treatment of cancer with indole derivatives
US8658637B2 (en)	2006-12-06	2014-02-25	Boehringer Ingelheim International Gmbh	Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
US20170065529A1 (en)	2015-09-09	2017-03-09	Boehringer Ingelheim International Gmbh	Pharmaceutical dosage form for immediate release of an indolinone derivative
AU2009256289A1 (en)	2008-06-06	2009-12-10	Boehringer Ingelheim International Gmbh	Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
WO2011032320A1 (en) *	2009-09-21	2011-03-24	F. Hoffmann-La Roche Ag	Novel alkene oxindole derivatives
EP2780322B1 (en)	2011-11-14	2018-05-16	Ligand Pharmaceuticals, Inc.	Methods and compositions associated with the granulocyte colony-stimulating factor receptor
WO2014150252A1 (en) *	2013-03-15	2014-09-25	Ligand Pharmaceuticals Incorporated	Methods of treatment associated with the granulocyte colony-stimulating factor receptor
CN107033064B (zh) *	2017-04-28	2019-07-09	西安医学院	一种3-(吗啉取代芳亚胺基)吲哚类化合物及其制备方法和应用
CN111285872B (zh) *	2018-12-06	2022-05-17	北京志健金瑞生物医药科技有限公司	吲哚-2-酮衍生物及其制备方法与用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9501567D0 (en) *	1995-01-26	1995-03-15	Pharmacia Spa	Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
US5880141A (en) *	1995-06-07	1999-03-09	Sugen, Inc.	Benzylidene-Z-indoline compounds for the treatment of disease
GB9718913D0 (en) *	1997-09-05	1997-11-12	Glaxo Group Ltd	Substituted oxindole derivatives
DE19824922A1 (de) *	1998-06-04	1999-12-09	Boehringer Ingelheim Pharma	Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
UA75054C2 (uk) *	1999-10-13	2006-03-15	Бьорінгер Інгельхайм Фарма Гмбх & Ко. Кг	Заміщені в положенні 6 індолінони, їх одержання та їх застосування як лікарського засобу

1998
- 1998-04-15 DE DE19816624A patent/DE19816624A1/de not_active Withdrawn
1999
- 1999-04-10 SK SK1513-2000A patent/SK283824B6/sk unknown
- 1999-04-10 AT AT99920635T patent/ATE251138T1/de active
- 1999-04-10 AU AU38149/99A patent/AU749829B2/en not_active Ceased
- 1999-04-10 ES ES99920635T patent/ES2207209T3/es not_active Expired - Lifetime
- 1999-04-10 HU HU0101568A patent/HUP0101568A3/hu unknown
- 1999-04-10 WO PCT/EP1999/002436 patent/WO1999052869A1/de active IP Right Grant
- 1999-04-10 ID IDW20002062A patent/ID26420A/id unknown
- 1999-04-10 EE EEP200000598A patent/EE04432B1/xx not_active IP Right Cessation
- 1999-04-10 DK DK99920635T patent/DK1071665T3/da active
- 1999-04-10 TR TR2000/02980T patent/TR200002980T2/xx unknown
- 1999-04-10 IL IL13803699A patent/IL138036A0/xx not_active IP Right Cessation
- 1999-04-10 CN CNB998050296A patent/CN100338036C/zh not_active Expired - Fee Related
- 1999-04-10 BR BR9909688-9A patent/BR9909688A/pt not_active Application Discontinuation
- 1999-04-10 NZ NZ507967A patent/NZ507967A/xx unknown
- 1999-04-10 KR KR1020007011454A patent/KR100588250B1/ko not_active IP Right Cessation
- 1999-04-10 EP EP99920635A patent/EP1071665B1/de not_active Expired - Lifetime
- 1999-04-10 PL PL99343314A patent/PL343314A1/xx not_active Application Discontinuation
- 1999-04-10 JP JP2000543432A patent/JP4015365B2/ja not_active Expired - Lifetime
- 1999-04-10 CA CA002323111A patent/CA2323111C/en not_active Expired - Fee Related
- 1999-04-10 PT PT99920635T patent/PT1071665E/pt unknown
- 1999-04-10 DE DE59907199T patent/DE59907199D1/de not_active Expired - Lifetime
- 1999-04-10 YU YU59800A patent/YU59800A/sh unknown
- 1999-04-10 EA EA200001021A patent/EA003532B1/ru not_active IP Right Cessation
- 1999-04-13 MY MYPI99001427A patent/MY122357A/en unknown
- 1999-04-14 CO CO99022218A patent/CO5011040A1/es unknown
- 1999-04-14 TW TW088105963A patent/TW510897B/zh active
- 1999-04-14 AR ARP990101700A patent/AR015763A1/es active Pending
- 1999-10-04 UA UA2000116456A patent/UA63009C2/uk unknown
2000
- 2000-09-04 ZA ZA200004623A patent/ZA200004623B/xx unknown
- 2000-09-29 BG BG104813A patent/BG64443B1/bg active Active
- 2000-10-13 NO NO20005151A patent/NO317298B1/no unknown

Also Published As

Publication number	Publication date
JP4015365B2 (ja)	2007-11-28
JP2002511449A (ja)	2002-04-16
CA2323111A1 (en)	1999-10-21
CN1297438A (zh)	2001-05-30
HUP0101568A2 (hu)	2001-09-28
PL343314A1 (en)	2001-08-13
EP1071665B1 (de)	2003-10-01
WO1999052869A1 (de)	1999-10-21
SK283824B6 (sk)	2004-02-03
EE200000598A (et)	2002-04-15
ES2207209T3 (es)	2004-05-16
BG64443B1 (en)	2005-02-28
TR200002980T2 (tr)	2001-02-21
PT1071665E (pt)	2004-02-27
AU749829B2 (en)	2002-07-04
EA003532B1 (ru)	2003-06-26
DE19816624A1 (de)	1999-10-21
MY122357A (en)	2006-04-29
NO20005151L (no)	2000-10-13
KR100588250B1 (ko)	2006-06-13
ZA200004623B (en)	2001-05-30
KR20010042731A (ko)	2001-05-25
BR9909688A (pt)	2000-12-19
SK15132000A3 (sk)	2001-03-12
IL138036A0 (en)	2001-10-31
HUP0101568A3 (en)	2002-12-28
ATE251138T1 (de)	2003-10-15
EE04432B1 (et)	2005-02-15
NO317298B1 (no)	2004-10-04
DE59907199D1 (de)	2003-11-06
YU59800A (sh)	2003-04-30
AU3814999A (en)	1999-11-01
DK1071665T3 (da)	2004-01-05
NZ507967A (en)	2003-04-29
UA63009C2 (en)	2004-01-15
BG104813A (en)	2001-08-31
NO20005151D0 (no)	2000-10-13
AR015763A1 (es)	2001-05-16
EP1071665A1 (de)	2001-01-31
CO5011040A1 (es)	2001-02-28
EA200001021A1 (ru)	2001-06-25
CA2323111C (en)	2009-09-15
CN100338036C (zh)	2007-09-19
TW510897B (en)	2002-11-21

Publication	Publication Date	Title
ID26420A (id)	2000-12-21	Indolinon-indolinon tersubstitusi baru, pembuatannya dan penggunaannya sebagai komposisi-komposisi farmasi
ID27035A (id)	2001-02-22	Indolinona tersubstitusi baru, pembuatannya dan penggunaannya sebagai komposisi farmasi
ID26305A (id)	2000-12-14	Benzamida tersubstitusi baru, pembuatan dan penggunaannya
EE200000468A (et)	2002-04-15	Ühendid, nende kasutamine ja farmatseutiline kompositsioon
HUP0200312A3 (en)	2002-12-28	Substituted 2-phenylbenzimidazoles, pharmaceutical compositions containing them, the production thereof and their use
ID25528A (id)	2000-10-12	Karboksamidotiazol tersubstitusi, pembuatannya dan komposisi farmasi yang mengandungnya
IS5665A (is)	2000-10-13	Lyfjafræðileg þrýstiúða samsetning
ID30299A (id)	2001-11-22	Turunan oksazolidinon, proses pembuatannya dan komposisi farmasi yang mengandungnya
ID27415A (id)	2001-04-05	Komposisi farmaseutik
ID28166A (id)	2001-05-10	Formulasi partikulat baru
FI991485A0 (fi)	1999-06-30	Uusi farmaseuttinen koostumus
ID16420A (id)	1997-09-25	Komposisi farmasi baru dengan efek anastesia
EA199900373A3 (ru)	2000-08-28	Фармацевтические композиции
EE200200175A (et)	2003-04-15	Asendatud 2-tio-3,5-ditsüano-4-arüül-6-aminopüridiinid ja nende kasutamine
ID18613A (id)	1998-04-23	Oksadiazol baru, proses pembuatannya serta penggunaannya sebagai komposisi farmasi
ID26774A (id)	2001-02-08	Senyawa benzimidazol, pembuatan dan penggunaannya sebagai komposisi farmasi
ID29089A (id)	2001-07-26	Sediaan farmasi moksifloksasin
ID26310A (id)	2000-12-14	Produksi kontinyu 1,3-dioksolan-2-ona
ID28997A (id)	2001-07-26	Kedok sekali pakai, dan proses pembuatannya
ID29262A (id)	2001-08-16	Komposisi farmasi
ID24714A (id)	2000-08-03	Turunan tiazolidindion tersubstitusi, proses pembuatannya dan penggunaan bahan farmasinya
EE05020B1 (et)	2008-06-16	Glburiidi ravimkoostis
ID27558A (id)	2001-04-12	Amida-amida aromatik baru, metode pembuatannya dan penggunaannya sebagai obat
ID27201A (id)	2001-03-08	Komposisi farmasi
ID20855A (id)	1999-03-18	Senyawa turunan imidazolidin baru, pembuatannya, penggunaannya dan sediaan farmasi yang mengandung senyawa tersebut